UTILISATION D'UNE SOUCHE DE BACTÉRIE GÉNÉTIQUEMENT MODIFIÉE, DÉNOMMÉE VPN20009-M, DANS LA PRÉPARATION DE MÉDICAMENTS DESTINÉS À LA PRÉVENTION ET AU TRAITEMENT D'UNE MÉTASTASE D'UN CANCER
The present invention discloses uses of genetically engineered attenuated Salmonella typhimurium strain VNP20009-M in the manufacture of medicaments for the preventing and treating cancer metastasis. The genetically engineered strain VNP20009-M is targeted to cancer cells and has a significant effect of inhibiting metastasis and growth. VNP20009-M can be used to prepare medicaments for the prevention and treatment of tumor metastasis.